Literature DB >> 20653164

Clinical observations on 100 cases of ulcerative colitis treated with the method of clearing away heat, expelling dampness, promoting blood circulation and healing ulcer.

Bai Ye1, Hong Shen, Yue Lu, Ya-qi Wang.   

Abstract

OBJECTIVE: To observe the clinical therapeutic effect of the method of clearing away heat, expelling dampness, promoting blood circulation and healing ulcer on ulcerative colitis.
METHODS: The 100 cases were randomly divided into a control group of 45 cases treated with retention enema of the enterosoluble tablet sulfasalazine once every evening and a treatment group of 55 cases treated with retention enema of the decoction for clearing away heat, expelling dampness, promoting blood circulation and healing ulcer once every evening. The patients in both groups orally took Chinese drug for basic treatment for 30 days as a course. After treatment, the clinical therapeutic effects in the 2 groups were compared and changed symptoms in intestinal mucosa were observed under endoscope.
RESULTS: The total effective rate of treatment group was better in relieving symptoms of TCM syndrome (90.9%) and intestinal mucosa (83.3%) than that of control group (68.9%, 56.3%) (P<0.01 or P<0.05).
CONCLUSION: With good therapeutic effect on ulcerative colitis, Qinghua Huoxue Lianyang therapy (clearing away heat, expelling dampness, promoting blood circulation and healing ulcer) can obviously repair intestinal mucosa.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20653164     DOI: 10.1016/s0254-6272(10)60022-2

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  7 in total

1.  Mechanisms of Paeonia lactiflora in Treatment of Ulcerative Colitis: A Network Pharmacological Study.

Authors:  Yin Zhang; Xiaoyan Li; Xianlin Xu; Ningxi Yang
Journal:  Med Sci Monit       Date:  2019-10-09

2.  Efficacy of herbal medicine (Gegen Qinlian Decoction) on ulcerative colitis: A systematic review of randomized controlled trials.

Authors:  Yuling Fan; Wen Yi; Han Huang; Zhigang Mei; Zhitao Feng
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

Review 3.  Efficacy and Safety of Sophora flavescens (Kushen) Based Traditional Chinese Medicine in the Treatment of Ulcerative Colitis: Clinical Evidence and Potential Mechanisms.

Authors:  Mingjun Chen; Yuxuan Ding; Zhanqi Tong
Journal:  Front Pharmacol       Date:  2020-12-10       Impact factor: 5.810

Review 4.  Based on Network Pharmacology to Explore the Potential Bioactive Compounds and Mechanisms of Zuojin Pill for the Treatment of Ulcerative Colitis.

Authors:  Ying Wei; Sichen Ren; Ruilin Wang; Manyi Jing; Honghong Liu; Min Wang; Hongtao Song; Yanling Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-26       Impact factor: 2.629

5.  Scientific Evidence of Chinese Herbal Medicine (Gegen Qinlian Decoction) in the Treatment of Ulcerative Colitis.

Authors:  Jinke Huang; Jiaqi Zhang; Yifan Wang; Jing Ma; Xuefei Yang; Xiaoxue Guo; Mi Lv; Jinxin Ma; Yijun Zheng; Fengyun Wang; Xudong Tang
Journal:  Gastroenterol Res Pract       Date:  2022-03-14       Impact factor: 2.260

6.  Molecular Targets and Mechanisms of Scutellariae radix-Coptidis rhizoma Drug Pair for the Treatment of Ulcerative Colitis Based on Network Pharmacology and Molecular Docking.

Authors:  Kai Niu; Qifang Li; Yuan Liu; Yi Qiao; Bingbing Li; Chao Wei; Kunrui Wang; Lu'an Cui; Canlei Zheng; Rong Wang; Li Zhang; Honghua Zhang; Bing Sun; Bin Yu
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-04       Impact factor: 2.629

7.  Modified Sijunzi decoction in the treatment of ulcerative colitis in the remission phase: study protocol for a series of N-of-1 double-blind, randomised controlled trials.

Authors:  Yi-Ming Chen; Jie-Min Deng; Yi Wen; Bin Chen; Jiang-Tao Hou; Bin Peng; Shi-Jing Zhang; Hong Mi; Qi-Long Jiang; Xia-Lin Wu; Feng-Bin Liu; Xin-Lin Chen
Journal:  Trials       Date:  2020-05-12       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.